Original:  Sources close to the discussions said Aurora is proposing a bid that is above its previous $24-a-share offer that CanniMed had rejected.
Updated: Sources close to the discussions said Aurora is proposing a bid that is well above its previous $24-a-share offer that CanniMed had rejected.